Herein we build upon work previously published by our group that identified chordoma CSCs with flow cytometry in four cell lines and showed that CSCs could be eliminated by avelumab (PD-L1 inhibitor)-mediated antibody dependent cellular cytotoxicity (ADCC) (20). Here, CD274 is linked to chordoma.